How HIV packages its envelope and spreads between cells

Identifying determinants of HIV-1 responsible for the nanoscale distribution and dynamics of virus assembly

NIH-funded research University of Denver (Colorado Seminary) · NIH-11325099

This project looks at how HIV’s surface protein (Env) gets packaged into new virus particles and moves between cells to help people living with HIV.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Denver (Colorado Seminary) NIH-funded
Lab location1 site (Denver, United States)
Project IDNIH-11325099 on NIH RePORTER

What this research studies

Researchers will use very high-resolution microscopes to watch individual HIV Env proteins in three dimensions as virus particles form on cell surfaces. They will change parts of the Env protein’s tail to see which pieces are needed for the protein to be included in new viruses. They will also study cell proteins that move Env to the surface to understand how host factors control virus assembly and cell-to-cell spread. All experiments are done in the lab using virus samples and cultured cells, and the team has preliminary data showing these methods can reveal nanoscale organization and movement.

Who could benefit from this research

Good fit: This grant does not enroll patients; the work is laboratory-based using virus samples and cultured cells rather than recruiting people.

Not a fit: Patients should not expect direct personal medical benefit from this project because it is basic lab research focused on understanding viral mechanisms.

Why it matters

Potential benefit: If successful, this work could identify new targets to block HIV assembly or cell-to-cell spread and eventually lead to better treatments or prevention strategies.

How similar studies have performed: Advanced super-resolution and single-molecule tracking methods have provided important insights in viral biology and the investigators’ preliminary data support that these approaches can reveal Env behavior, though turning those findings into therapies remains a new step.

Where this research is happening

Denver, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.